EFFECTS OF STEROID-HORMONES ON FIBRINOLYTIC SYSTEM IN CULTURED HUMAN ENDOMETRIAL CELLS

被引:8
作者
MIYAUCHI, A [1 ]
OSUGA, Y [1 ]
TAKETANI, Y [1 ]
机构
[1] UNIV TOKYO,FAC MED,DEPT OBSTET & GYNECOL,BUNKYO KU,TOKYO 113,JAPAN
关键词
TISSUE-TYPE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR-1; PROGESTERONE; HUMAN ENDOMETRIUM;
D O I
10.1507/endocrj.42.57
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a primary human endometrial cell culture, the addition of progesterone resulted in an approximately 2-fold increase in the amount of tissue-type plasminogen activator (t-PA) released into the culture media, with the minimal effective dose being 10(-7) M. In contrast, progesterone significantly reduced the release of urokinase-type PA (u-PA). Endometrial cells are known to release a major PA inhibitor, PAI-1. Progesterone stimulated the release of PAI-1. These observed effects of progesterone seem to be mediated through the progestin receptor in that R5020, a specific ligand for progestin receptor, mimicked the effects of progesterone, and RU486, an antagonist of progesterone, completely eliminated the effects of progesterone. It is notable that estradiol, when added alone or in combination with progesterone, caused no discernible effect on the release of PAs and PAI-1. These results suggest that progesterone is a key hormone in regulating the PA/plasmin system in the human endometrum, thereby playing a pivotal role in implantation and ensuing embryonal development.
引用
收藏
页码:57 / 62
页数:6
相关论文
共 14 条
[1]   THE FIBRINOLYTIC ACTIVITY OF THE HUMAN ENDOMETRIUM [J].
ALBRECHTSEN, OK .
ACTA ENDOCRINOLOGICA, 1956, 23 (02) :207-218
[2]  
CASSLEN B, 1986, P SOC EXP BIOL MED, V182, P419
[3]   FIBRINOLYTIC-ACTIVITY OF HUMAN UTERINE FLUID [J].
CASSLEN, B ;
ASTEDT, B .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1981, 60 (01) :55-58
[4]   EXPRESSION OF CELL-MEMBRANE RECEPTORS FOR UROKINASE PLASMINOGEN-ACTIVATOR (U-PA) IN THE HUMAN ENDOMETRIUM INCREASES DURING THE OVARIAN CYCLE [J].
CASSLEN, B ;
GUSTAVSSON, B .
FIBRINOLYSIS, 1991, 5 (04) :243-248
[5]   PLASMINOGEN ACTIVATORS IN THE HUMAN ENDOMETRIUM, CELLULAR-ORIGIN AND HORMONAL-REGULATION [J].
CASSLEN, B ;
URANO, S ;
LECANDER, I ;
NY, T .
BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (02) :133-138
[6]   OCCURRENCE OF BOTH UROKINASE AND TISSUE PLASMINOGEN-ACTIVATOR IN THE HUMAN-ENDOMETRIUM [J].
CASSLEN, B ;
ASTEDT, B .
CONTRACEPTION, 1983, 28 (06) :553-564
[7]   CYCLIC CHANGES IN ENDOMETRIAL TISSUE-PLASMINOGEN ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN WOMEN WITH NORMAL MENSTRUATION AND ESSENTIAL MENORRHAGIA [J].
GLEESON, NC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 171 (01) :178-183
[8]   PLASMINOGEN ACTIVATORS AND THEIR INHIBITORS - REGULATORS OF EXTRACELLULAR PROTEOLYSIS AND CELL-FUNCTION [J].
HART, DA ;
REHEMTULLA, A .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1988, 90 (04) :691-708
[9]  
KOK P, 1979, THROMB HAEMOSTASIS, V41, P718
[10]   TUMOR-NECROSIS-FACTOR AND EPIDERMAL GROWTH-FACTOR MODULATE MIGRATION OF HUMAN MICROVASCULAR ENDOTHELIAL-CELLS AND PRODUCTION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR [J].
MAWATARI, M ;
OKAMURA, K ;
MATSUDA, T ;
HAMANAKA, R ;
MIZOGUCHI, H ;
HIGASHIO, K ;
KOHNO, K ;
KUWANO, M .
EXPERIMENTAL CELL RESEARCH, 1991, 192 (02) :574-580